24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
@Finance
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Atox Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:33
Apple agrees to build chips with Intel in the U.S., Trump says
10:02
Imperva: “A hybrid and flexible model is no longer a perk, it is an essential part of maintaining balance”
09:25
Novee Security appoints Arad Offer as VP of Finance
09:17
Two years after a $2.7 billion return to Google, AI pioneer Noam Shazeer is leaving for OpenAI
More stories
Buzz
Most popular
Daily
Weekly
1
Jewish family from Mexico donates NIS 200 million to establish Israel's largest rehabilitation hospital
2
After raising $20 million, collapsed startup Swish.ai sells to Unframe for just $150,000
3
Echo: “Employees have become very good at identifying performative culture”
4
After PTSD and years of insomnia, Israeli founder raises $6.5 million to improve sleep through scent
5
More than 50 years after its debut, Israel's Kfir fighter jet gets a new lease on life
More news
Atox Bio
2 stories about Atox Bio
CTech’s Daily Israeli Tech News Roundup
04.12.17
|
CTech
Bank of China partners with Israeli bank to finance Israeli companies in China. Medinol receives FDA approval for the drug-eluting stent. Israel plans solar energy push
Adams Street Partners Backs Critical Care Treatment Startup Atox Bio
04.12.17
|
Lilach Baumer
The company's leading product is currently being tested in clinical trials for the treatment of flesh-eating bacteria and kidney failure